Want to track NOVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novartis AG (NOVN) Statistics
Valuation metrics
Market Cap 228.63B
Enterprise value 337.9B
Trailing P/E (ttm) 23.66
Forward P/E -
PEG ratio -5.27
Price/Sales (ttm) 5.41
Price/Book (mrq) 7.13
Enterprise Value/Revenue 6.17
Enterprise Value/EBITDA 15.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.97M
Average volume (90 days) 2.39M
Price summary
52-Week low 95.59
52-Week high 131.5
Beta -
50-Day moving average 125.32
200-Day moving average 121.03
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 4.58
Trailing annual dividend yield 0.0294%
5-Year annual dividend yield -
Payout ratio 0.68
Dividend Date 12 Mar 2026
Ex-Dividend Date 10 Mar 2026
Last split factor 6:5
Last split Date 4 Oct 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.23%
Operating margin 0.3%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 28.76
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 6.64
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.05
Total debt (mrq) -
Total Debt/Equity (mrq) 1.18
Current ratio (mrq) 0.86%
Book value per share (mrq) 22.08
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
